Results 201 to 210 of about 92,971 (266)

A new c.681dup RUNX1 variant in familial leukemia. [PDF]

Fam Cancer
Crocioni M, Nardelli C, Lema Fernandez AG, Bardelli V, Pierini V, Matteucci C, Beggiato E, Olivi M, Vigliani V, Pelle A, Lanzarone G, Mecucci C.   +11 more
europepmc   +1 more source

Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced‐stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study

HemaSphere, Volume 10, Issue 6, June 2026.
Abstract Follicular lymphoma (FL) is the most common indolent lymphoma. Although chemoimmunotherapy is effective, toxicity remains problematic, and novel treatments are required. We performed a Phase Ib/II study of obinutuzumab, lenalidomide, and venetoclax in patients with treatment‐naïve, high tumor burden, advanced‐stage FL. During induction (6 × 28‐
Chan Y. Cheah, Piers Blombery, Amanda Johnston, Joel Wight, Katharine L. Lewis, Rory Bennett, Jing Xie, Stella Vlachos, Sally M. Hunter, Joyce Gonzales, Sally Binks, John F. Seymour   +11 more
wiley   +1 more source

Composite Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Diagnostic and Therapeutic Challenge. [PDF]

EJHaem
Ye MT, Yang Y, You MJ.
europepmc   +1 more source

[A case of lymphoid leukemia].

Actas dermo-sifiliograficas, 2003
P A, QUINONES, T, FUENTES
openaire   +1 more source

Folate receptor beta targeting of tumor‐associated macrophages improves lymphoma cell responses to CD19 CAR T cells

HemaSphere, Volume 10, Issue 6, June 2026.
Abstract Chimeric antigen receptor (CAR) T cell therapies have revolutionized the treatment of patients with relapsed or refractory (R/R) diffuse large B‐cell lymphoma (DLBCL). However, approximately half of the patients experience lymphoma progression after CD19 CAR T cell therapy.
Kerttu Kalander, Katri Oksa, Selma Sorri, Hector Monzo, Suvi‐Katri Leivonen, Päivi M. Ojala, Sirpa Leppä   +6 more
wiley   +1 more source

Pediatric mediastinal tumor unveiled as T-cell prolymphocytic leukemia: diagnostic pitfalls-a case report. [PDF]

J Med Case Rep
Çalışkan Kamış Ş, Karagün BŞ, Adamhasan F, Koç AS.   +3 more
europepmc   +1 more source

EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation

HemaSphere, Volume 10, Issue 6, June 2026.
Abstract Previous editions of the European guidelines for the management of chronic lymphocytic leukemia (CLL) were developed by experts in CLL under the auspices of the European Society for Medical Oncology (ESMO). These previous editions have served as a reference text for many physicians caring for patients with CLL.
Barbara Eichhorst, Paolo Ghia, Francesc Bosch, Ruth Clifford, Michael Gregor, Romain Guieze, Arnon P. Kater, Carsten U. Niemann, Sarka Pospisilova, Tadeusz Robak, Anna Schuh, Kostas Stamatopoulos, Tamar Tadmor, Nick York   +13 more
wiley   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Acute Lymphoid Leukemia

Pediatric Annals, 1983
During the past decade progress in the treatment of childhood acute lymphoblastic leukemia has slowed. A 50% to 60% cure barrier has frustrated a multitudinous array of therapeutic attempts to overcome this obstacle. With few exceptions, intensifications of induction, consolidation, or maintenance therapies have not overcome this obstacle.
openaire   +2 more sources

Chronic Lymphoid Leukemia

Acta Haematologica, 2009
223 cases with chronic lymphoid leukemia (CLL) were subjected to a prospective study on the presence of adeno- and splenomegaly at diagnosis and their subsequent variation. Subjects with no initial organ involvement were usually female (76%) and of old age (mean 69.2 years).
W. Paolino, V. Infelise, M. Rossi, F. Paolino, F. Locatelli, L. Caramellino, A. Levis   +6 more
openaire   +1 more source